News & Analysis as of

Medical Marijuana Marijuana Cannabidiol (CBD) oil

Medical Marijuana refers to the use of marijuana to treat or alleviate symptoms of certain illnesses. A growing number of states permit individuals to use marijuana on the recommendation of a physician. Despite... more +
Medical Marijuana refers to the use of marijuana to treat or alleviate symptoms of certain illnesses. A growing number of states permit individuals to use marijuana on the recommendation of a physician. Despite state laws to the contrary, Federal law still prohibits the use or possession of marijuana. The conflict between state and federal law on this issue has created interesting enforcement issues and significant legal hurdles for medical marijuana providers.  less -
Poyner Spruill LLP

Fourth Circuit Affirms Termination of Employee for Alleged Lawful THC Consumption

Poyner Spruill LLP on

North Carolina employees are increasingly testing positive for illegal marijuana use while contending that they were only using legal hemp-derived products sold over the counter in this State. Some employees assert that these...more

Parker Poe Adams & Bernstein LLP

Lawful Products Statutes Complicate Employers' Response to Employees' Claims of CBD Use

Over the past year, we have encountered a growing number of claims raised by applicants and employees who allege that positive drug test results for marijuana were actually the result of their use of legal hemp products...more

Jackson Lewis P.C.

U.S. Drug Enforcement Administration Recommends Rescheduling Marijuana To Schedule III, Similar to Tylenol With Codeine

Jackson Lewis P.C. on

The U.S. Drug Enforcement Administration will recommend that marijuana should be rescheduled from a Schedule I drug to a Schedule III drug, according to an announcement made April 30, 2024 by the U.S. Department of Justice. ...more

Fox Rothschild LLP

New Adult-Use Cannabis Law Proposed in Pennsylvania

Fox Rothschild LLP on

Pennsylvania once again seems to have momentum to become one of the next states to legalize cannabis for adult use. After a bipartisan bill was introduced in the commonwealth’s Senate last year, the House now has submitted an...more

Seyfarth Shaw LLP

The Week in Weed: December 2023 # 2

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we have an update on Ohio, where legislators are re-writing the cannabis initiative language. We check in...more

Troutman Pepper

Georgia to Become First State in the Nation to Allow Medical Marijuana in Pharmacies

Troutman Pepper on

The Georgia Board of Pharmacy has begun accepting applications from independent, licensed pharmacies for authorization to dispense authorized medical marijuana products, and nearly 120 pharmacies reportedly have agreed to...more

Vicente LLP

Cannabis and Hemp Developments in North Carolina

Vicente LLP on

Public support for medical cannabis in North Carolina is quite strong. In fact, according to a Meredith College poll conducted in February 2023, 73% of North Carolina voters, including 64% of Republicans, support a law...more

Bradley Arant Boult Cummings LLP

Some of It’s Magic, Some of It’s Tragic: Jimmy Buffett and American Cannabis Policy

Jimmy Buffett was a spirit animal of the Budding Trends blog. We don’t quote from him as often as we do the Grateful Dead, Phish, Widespread Panic, or popular movies, but maybe because in many ways his lyrics are too good for...more

Foley Hoag LLP - Cannabis and the Law

The Cannabis Rescheduling Recommendation: What it Means and What’s Next

In light of the August 30, 2023 historic recommendation from the U.S. Department of Health and Human Services (HHS) to reschedule cannabis to Schedule III, a multidisciplinary group of attorneys from Foley Hoag’s nationwide...more

Benesch

Cannabis Industry Quarterly Update: Q2 2023

Benesch on

There Has Been Little Movement in Federal Legalization. This has led to cannabis investors and companies to downgrade expectations for federal legalization and focus their strategies on state reform. Federal lawmakers...more

McGlinchey Stafford

Rescheduling Marijuana: Understanding the Legal Impacts

McGlinchey Stafford on

Marijuana is currently listed as a Schedule I substance in the Controlled Substances Act (CSA); this scheduling means the federal government concluded marijuana has no currently accepted medical use in any setting. This could...more

Seyfarth Shaw LLP

The Week in Weed: July 2023 # 2

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we check in on Pennsylvania, Ohio and Virginia – each state is in a different place and heading in a...more

Clark Hill PLC

Q2 Cannabis Industry Group Newsletter

Clark Hill PLC on

Welcome to your quarterly rundown of the latest legal, policy, and market happenings in the cannabis and hemp industry. The Intoxicating Hemp Derivatives Market: By Robert Hoban - All of the hemp plant’s uses and...more

Cozen O'Connor

Minnesota Adult-Use Cannabis Bill Emerges from Reconciliation

Cozen O'Connor on

On April 25, 2023, the Minnesota House passed House File 100 (HF100), a bill authorizing adult-use cannabis, by a vote of 71-59. Three days later, the Minnesota Senate passed Senate File 73 (SF73), a companion bill to HF100,...more

Seyfarth Shaw LLP

The Week in Weed: March 2023 #4

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we see action on a federal CBD bill. Kentucky advances a medical marijuana bill, while Kansas...more

Clark Hill PLC

Could Pennsylvania Legalize Recreational Cannabis in 2023?

Clark Hill PLC on

Historically, Pennsylvania has not been considered a “state to watch” regarding the legalization of recreational adult use cannabis. That could change in 2023 with Democrat Josh Shapiro’s inauguration as the state’s newest...more

Hogan Lovells

FDA asks Congress to legislate CBD approval pathway, as new law permits marijuana & CBD research - FDA determines food and dietary...

Hogan Lovells on

In an official statement last week, the U.S. Food and Drug Administration (FDA) announced its conclusion that the existing regulatory framework for foods and dietary supplements is not appropriate for the regulation of...more

McDermott Will & Emery

Doctor-Patient Relationships and Medical Marijuana: Where Are We Now?

McDermott Will & Emery on

On December 2, 2022, President Joseph Biden signed the Medical Marijuana and Cannabidiol Research Expansion Act (Cannabis Research Act), which provides a mechanism for industry and academia to access and research cannabis,...more

ArentFox Schiff

New Law Eases Federal Restrictions on Medical Marijuana Research and Cultivation

ArentFox Schiff on

The Medical Marijuana and Cannabidiol Research Expansion Act (MMCREA) became law last Friday. The bipartisan legislation will roll back federal restrictions on medical marijuana research and the cultivation of research-grade...more

The Rodman Law Group, LLC

Medical Marijuana and Cannabidiol Research Expansion Act

With young adults’ marijuana use at an all-time high as states continue to pass legislation legalizing marijuana for medical and/or recreational use, the federal government is, at long last, taking a closer look. As we...more

Dunlap Bennett & Ludwig PLLC

Researching Potential Medical Benefits of Cannabis Moves a Step Closer – sort of.

Cannabis legalization advocates are quick to point out a Catch-22 in current legalization debates. On one hand, Cannabis is a Schedule 1 drug under the Controlled Substances Act....more

Kelley Drye & Warren LLP

CBD and Hemp Legal and Regulatory Roundup – July 2022 #3

Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news: CBD - Physicians remain reluctant to prescribe CBD for epilepsy While the FDA has approved cannabis-derived prescription drug,...more

McGuireWoods LLP

In the Weeds: Top Court Declines Workers’ Compensation Case, MLB Permits CBD Sponsorship, Buyer Beware Delta-9

McGuireWoods LLP on

Newsworthy Highlights - Supreme Court Refuses to Hear Medical Cannabis Workers’ Compensation Case. On June 21, 2022, the U.S. Supreme Court denied two petitions for a writ of certiorari brought by injured workers in...more

Kelley Drye & Warren LLP

CBD and Hemp Legal and Regulatory Roundup – June 2022

Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news: CBD - State lawmakers haphazardly approach hemp-derived Delta-8 THC...more

McGuireWoods LLP

In the Weeds: FDA Warns Against CBD for Food-Producing Animals, Okla. Suspends Lab License, Calif. Launches Cannabis Access Map

McGuireWoods LLP on

Newsworthy Highlights - FDA Continues CBD Warnings; Sends Letters to Companies Selling CBD Products for Food-Producing Animals. On May 26, 2022, the U.S. Food and Drug Administration (FDA) issued warning letters to four...more

145 Results
 / 
View per page
Page: of 6

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide